Substances (GSRS)

N-(4-METHOXY-2-(METHYLAMINO)-5-((4-(1-METHYLINDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)PROP-2-ENAMIDE

Also: OSIMERTINIB METABOLITE M2

chemicalUNII BCQ0XF3C37
Open FDA's page for this record
Substance class
chemical
Definition type
PRIMARY
Definition level
COMPLETE
Uuid
af9f7f11-2055-41f9-a9d6-fcb94a478cda
Version
6
UNII
BCQ0XF3C37
Codes
  1. Uuid
    0749fae4-4e0c-3331-a729-8d592106035c
    Code
    145022764
    Type
    PRIMARY
    Url
    https://pubchem.ncbi.nlm.nih.gov/compound/145022764
    Code system
    PUBCHEM
    References
    9372cb4c-37b8-b243-57b1-67a6c626dd69
  2. Uuid
    c153c59f-4bff-4394-8d8e-02b9f7516258
    Code
    BCQ0XF3C37
    Type
    PRIMARY
    Code system
    FDA UNII
Relationships
  1. Uuid
    cb451f18-114b-4506-8da2-958a5a9e87fa
    Comments
    This metabolite was detected in human hepatocytes.
    Type
    PARENT->METABOLITE
    Amount
    Uuid
    963ec0f9-c482-4ec9-bf25-b5366e768b62
    Mediator substance
    Uuid
    54fb5f1c-ddae-47bd-8591-10babff9dc90
    Refuuid
    4275827d-e329-4907-95b5-7d690692872a
    Name
    CYTOCHROME P450 3A4
    UNII
    PUO0521HZV
    Linking ID
    PUO0521HZV
    Ref pname
    CYTOCHROME P450 3A4
    Substance class
    reference
    References
    c2eb35db-5177-4503-b183-cc9840ede8e2, 73d71802-5e64-4145-92f5-41b93f7fcbac
    Related substance
    Uuid
    77281dda-74aa-45fa-92fe-8b0a35cc3713
    Refuuid
    9b9f5ca4-6cd2-42f0-978a-ffd260edd21a
    Name
    OSIMERTINIB
    UNII
    3C06JJ0Z2O
    Linking ID
    3C06JJ0Z2O
    Ref pname
    OSIMERTINIB
    Substance class
    reference
Names
  1. Uuid
    9b213e34-f9fa-e114-c6eb-3e6498496085
    Name
    N-(4-METHOXY-2-(METHYLAMINO)-5-((4-(1-METHYLINDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)PROP-2-ENAMIDE
    StdName
    N-(4-METHOXY-2-(METHYLAMINO)-5-((4-(1-METHYLINDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)PROP-2-ENAMIDE
    Type
    sys
    Preferred
    false
    Display name
    true
    Languages
    en
    References
    f84199b4-c0e5-90f2-8564-9385997585ba
  2. Uuid
    95ecc220-34ec-de7c-f74b-ab5d3e2a6096
    Name
    OSIMERTINIB METABOLITE M2
    StdName
    OSIMERTINIB METABOLITE M2
    Type
    cn
    Preferred
    false
    Display name
    false
    Languages
    en
    References
    628fc597-462e-773d-870f-c23c02c23535
References
  1. Uuid
    628fc597-462e-773d-870f-c23c02c23535
    Url
    http://dmd.aspetjournals.org/content/44/8/1201
    Doc type
    JA
    Public domain
    true
    Citation

    Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor Paul A. Dickinson, Mireille V. Cantarini, Jo Collier, Paul Frewer, Scott Martin, Kathryn Pickup and Peter Ballard Drug Metabolism and Disposition August 2016, 44 (8) 1201-1212; DOI: https://doi.org/10.1124/dmd.115.069203

    Tags
    PUBLIC_DOMAIN_RELEASE
  2. Uuid
    f84199b4-c0e5-90f2-8564-9385997585ba
    Citation
    FDA_SRS
    Doc type
    SRS
    Public domain
    true
    Tags
    PUBLIC_DOMAIN_RELEASE
  3. Uuid
    9372cb4c-37b8-b243-57b1-67a6c626dd69
    Citation
    PUBCHEM
    Doc type
    PUBCHEM
    Public domain
    true
  4. Uuid
    c2eb35db-5177-4503-b183-cc9840ede8e2
    Url
    http://dmd.aspetjournals.org/content/44/8/1201
    Doc type
    JA
    Public domain
    true
    Citation

    Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor Paul A. Dickinson, Mireille V. Cantarini, Jo Collier, Paul Frewer, Scott Martin, Kathryn Pickup and Peter Ballard Drug Metabolism and Disposition August 2016, 44 (8) 1201-1212; DOI: https://doi.org/10.1124/dmd.115.069203

    Tags
    PUBLIC_DOMAIN_RELEASE
  5. Uuid
    73d71802-5e64-4145-92f5-41b93f7fcbac
    Url
    https://aacrjournals.org/clincancerres/article/24/9/2138/81334/Identification-of-Novel-Pathways-of-Osimertinib
    Doc type
    JA
    Public domain
    true
    Citation

    MacLeod, A. Kenneth, et al. "Identification of Novel Pathways of Osimertinib Disposition and Potential Implications for the Outcome of Lung Cancer TherapyOsimertinib Metabolism in Humanized Mice." Clinical Cancer Research 24.9 (2018): 2138-2147.

Moieties
  1. Uuid
    20fc53a0-9941-3e4c-ea88-2ac0b343c708
    ID
    20fc53a0-9941-3e4c-ea88-2ac0b343c708
    Smiles
    C=CC(=O)Nc1cc(c(cc1NC)OC)Nc2nccc(-c3cn(C)c4ccccc34)n2
    Formula
    C24H24N6O2
    Atropisomerism
    No
    Charge
    0
    Count
    1
    Stereochemistry
    ACHIRAL
    Defined stereo
    0
    Ez centers
    0
    Molecular weight
    428.4873
    Optical activity
    NONE
    Stereo centers
    0
    Molfile

    Marvin 01132101522D 32 35 0 0 0 0 999 V2000 14.3511 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.6866 -1.5787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.4936 -1.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.5799 -2.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8261 -2.9062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.2741 -2.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.4672 -2.4647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.2122 -3.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7643 -3.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5711 -3.6908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2944 -2.9832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2944 -3.8081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -4.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -5.0456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -5.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -5.0456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -4.2206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.1522 -3.8081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.1522 -5.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.1522 -6.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -6.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -6.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -7.5206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -7.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -7.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2944 -7.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -8.7581 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.8667 -6.6956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 19.8667 -7.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -3.8081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -2.9832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -2.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 2 6 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 4 11 1 0 0 0 0 6 5 1 0 0 0 0 5 10 2 0 0 0 0 6 7 2 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 10 9 1 0 0 0 0 11 12 2 0 0 0 0 11 32 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 13 30 2 0 0 0 0 14 15 1 0 0 0 0 15 16 2 0 0 0 0 15 22 1 0 0 0 0 16 17 1 0 0 0 0 16 19 1 0 0 0 0 17 18 1 0 0 0 0 19 20 2 0 0 0 0 21 20 1 0 0 0 0 20 28 1 0 0 0 0 22 21 2 0 0 0 0 21 23 1 0 0 0 0 23 24 1 0 0 0 0 24 25 1 0 0 0 0 24 27 2 0 0 0 0 25 26 2 0 0 0 0 28 29 1 0 0 0 0 31 30 1 0 0 0 0 32 31 2 0 0 0 0 M END

    Count amount
    Type
    MOL RATIO
    Average
    1
    Units
    MOL RATIO
    Uuid
    0fe312c1-786d-4daa-8f4d-8c356c235db1
Structure
ID
16358dd4-62f6-1e85-3ebc-a043a467d0ef
Smiles
C=CC(=O)Nc1cc(c(cc1NC)OC)Nc2nccc(-c3cn(C)c4ccccc34)n2
Formula
C24H24N6O2
Atropisomerism
No
Charge
0
Count
1
Stereochemistry
ACHIRAL
Defined stereo
0
Ez centers
0
Molecular weight
428.4873
Optical activity
NONE
Stereo centers
0
Molfile

Marvin 01132101212D 32 35 0 0 0 0 999 V2000 14.3511 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.6866 -1.5787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.4936 -1.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.5799 -2.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8261 -2.9062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.2741 -2.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.4672 -2.4647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.2122 -3.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7643 -3.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5711 -3.6908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2944 -2.9832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2944 -3.8081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -4.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -5.0456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -5.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -5.0456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -4.2206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.1522 -3.8081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.1522 -5.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.1522 -6.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -6.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -6.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.4376 -7.5206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -7.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -7.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2944 -7.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -8.7581 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.8667 -6.6956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 19.8667 -7.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -3.8081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.7233 -2.9832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0087 -2.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 6 5 1 0 0 0 0 2 6 1 0 0 0 0 6 7 2 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 10 9 1 0 0 0 0 5 10 2 0 0 0 0 4 11 1 0 0 0 0 11 12 2 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 2 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 16 19 1 0 0 0 0 19 20 2 0 0 0 0 21 20 1 0 0 0 0 22 21 2 0 0 0 0 15 22 1 0 0 0 0 21 23 1 0 0 0 0 23 24 1 0 0 0 0 24 25 1 0 0 0 0 25 26 2 0 0 0 0 24 27 2 0 0 0 0 20 28 1 0 0 0 0 28 29 1 0 0 0 0 13 30 2 0 0 0 0 31 30 1 0 0 0 0 32 31 2 0 0 0 0 11 32 1 0 0 0 0 M END

References
f84199b4-c0e5-90f2-8564-9385997585ba
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.